Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 2/20 | 0.30 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | SI | P14410 | 2/20 | 0.30 |
| ▸ | MGAM2 | Q2M2H8 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL353238 | 0.85 | — | — | |
| SCHEMBL224303 | 0.85 | — | — | |
| SCHEMBL25906951 | 0.84 | TSHR (0.40) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 | |
| SCHEMBL15004183 | 0.83 | — | — | |
| SCHEMBL197339 | 0.83 | SMN1; SMN2 (0.40) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 | |
| SCHEMBL22710491 | 0.83 | SMN1; SMN2 (0.36) | SMN1; SMN2CA14 | |
| SCHEMBL15704457 | 0.83 | SMN1; SMN2 (0.36) | SMN1; SMN2CA14 | |
| SCHEMBL23028852 | 0.81 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 | |
| Potassium Ion SCHEMBL31028794 | 0.81 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 | |
| SCHEMBL7638966 | 0.81 | SMN1; SMN2 (0.41) | SMN1; SMN2CA14ALDH1A1KMT2ACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 321 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119882351-A | High-adhesion positive KrF photoresist resin composition | 万华化学集团股份有限公司 | 2025-04-25 | — | — | CN | claimed |
| CN-118186152-A | Multifunctional high-absorption chrome tanning auxiliary agent containing barbituric acid structure and preparation method thereof | 南京工业大学 | 2024-06-14 | — | — | CN | claimed |
| CN-111635312-B | Synthesis method of (E) -2-fluoroalkyl-3-butenoate compound | 安阳师范学院 | 2023-02-21 | — | — | CN | claimed |
| CN-111138462-B | Preparation method and application of 2-fluoro-malonic acid lithium difluoroborate | 江苏国泰超威新材料有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-109824512-B | Preparation method of 2-fluoro dimethyl malonate | 国药集团化学试剂有限公司 | 2021-06-08 | — | — | CN | claimed |
| CN-111635312-A | Synthesis method of (E) -2-fluoroalkyl-3-butenoate compound | 安阳师范学院 | 2020-09-08 | — | — | CN | claimed |
| CN-111138462-A | Preparation method and application of lithium 2-fluoro-malonate difluoroborate | 江苏国泰超威新材料有限公司 | 2020-05-12 | — | — | CN | claimed |
| CN-110963955-A | Synthesis method of monofluoro spiro compound and intermediate thereof | 南京富润凯德生物医药有限公司 | 2020-04-07 | — | — | CN | claimed |
| CN-110627718-A | Synthesis method of (E) -beta-monofluoroalkyl-beta, gamma-unsaturated amide | 安阳师范学院 | 2019-12-31 | — | — | CN | claimed |
| EP-0249867-B1 | SUBSTITUTED PHENYL ESTERS OF ALPHA-FLUOROACRYLIC ACID | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-01-02 | — | — | EP | claimed |
| EP-0203462-B1 | ALPHA-FLUOROACRYLIC-ACID ESTERS AND THEIR POLYMERS | HOECHST AKTIENGESELLSCHAFT (DE) | 1990-08-01 | — | — | EP | claimed |
| EP-0249867-A2 | Substituted phenyl esters of alpha-fluoroacrylic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-12-23 | — | — | EP | claimed |
| EP-0203462-A2 | Alpha-fluoroacrylic-acid esters and their polymers | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-12-03 | — | — | EP | claimed |
| US-12617802-B2 | Sulfonimidamide compounds as NLRP3 modulators | GENENTECH, INC. (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260109714-A1 | PYRIMIDINE-FUSED RING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | GENFLEET THERAPEUTICS SHANGHAI INC (CN) | 2026-04-23 | — | — | US | disclosed |
| US-20250346613-A1 | BORIC ACID PROTEASOME INHIBITOR AND USE THEREOF | ARTIVILA BIOPHARMA (CN) | 2025-11-13 | — | — | US | disclosed |
| EP-0334966-A1 | PROCESS FOR SYNTHESIZING OPTICALLY ACTIVE COMPOUNDS | NGK INSULATORS, LTD. (JP) | 1989-10-04 | — | — | EP | disclosed |
| EP-0249867-A2 | Substituted phenyl esters of alpha-fluoroacrylic acid | HOECHST AKTIENGESELLSCHAFT (DE) | 1987-12-23 | — | — | EP | disclosed |
| EP-0203462-A2 | Alpha-fluoroacrylic-acid esters and their polymers | HOECHST AKTIENGESELLSCHAFT (DE) | 1986-12-03 | — | — | EP | disclosed |
| EP-0052339-A1 | Fluorobarbituric acid derivatives and their preparation | Daikin Kogyo Co., Ltd. (JP) | 1982-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346613-A1 | BORIC ACID PROTEASOME INHIBITOR AND USE THEREOF | PSMA1, PSMB11, PSMB1 | SMN1; SMN2 1449/4885CA14 3144/4885ALDH1A1 2948/4885 |
| US-20260109714-A1 | PYRIMIDINE-FUSED RING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | KRAS, NRAS, HRAS | SMN1; SMN2 4243/4885CA14 1586/4885ALDH1A1 1260/4885 |
| US-12617802-B2 | Sulfonimidamide compounds as NLRP3 modulators | NLRP3, NLRP1, PYCARD | SMN1; SMN2 2586/4885CA14 3490/4885ALDH1A1 2022/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.